Gabriella Gobbi
Gabriella Gobbi
Professor, McGill University, Montreal, Canada
Verified email at - Homepage
Cited by
Cited by
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis
G Gobbi, T Atkin, T Zytynski, S Wang, S Askari, J Boruff, M Ware, ...
JAMA psychiatry 76 (4), 426-434, 2019
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
C Heurteaux, G Lucas, N Guy, M El Yacoubi, S Thümmler, XD Peng, ...
Nature neuroscience 9 (9), 1134-1141, 2006
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex
FR Bambico, N Katz, G Debonnel, G Gobbi
Journal of Neuroscience 27 (43), 11700-11711, 2007
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
L Santarelli, G Gobbi, PC Debs, EL Sibille, P Blier, R Hen, MJS Heath
Proceedings of the National Academy of Sciences 98 (4), 1912-1917, 2001
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
D De Gregorio, RJ McLaughlin, L Posa, R Ochoa-Sanchez, J Enns, ...
Pain 160 (1), 136, 2019
Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery
T Atkin, S Comai, G Gobbi
Pharmacological reviews 70 (2), 197-245, 2018
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
SBJ Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, Aldenkamp AP
Pharmacological Reviews 68 (3), 563-602, 2016
Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission
FR Bambico, NT Nguyen, N Katz, G Gobbi
Neurobiology of disease 37 (3), 641-655, 2010
CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
S Comai, G Gobbi
Journal of Psychiatry and Neuroscience 39 (1), 6-21, 2014
Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design
J Mazella, O Pétrault, G Lucas, E Deval, S Béraud-Dufour, C Gandin, ...
PLoS biology 8 (4), e1000355, 2010
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation
P Blier, G Gobbi, JE Turcotte, C de Montigny, N Boucher, C Hébert, ...
European Neuropsychopharmacology 19 (7), 457-465, 2009
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
B Lacoste, D Angeloni, S Dominguez‐Lopez, S Calderoni, A Mauro, ...
Journal of pineal research 58 (4), 397-417, 2015
Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study
G Gobbi, DL Murphy, KP Lesch, P Blier
Journal of Pharmacology and Experimental Therapeutics 296 (3), 987-995, 2001
The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
MN Hill, CJ Hillard, FR Bambico, S Patel, BB Gorzalka, G Gobbi
Trends in pharmacological sciences 30 (9), 484-493, 2009
The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology
S Comai, M Tau, G Gobbi
Journal of clinical psychopharmacology 32 (1), 83-94, 2012
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress
FR Bambico, NT Nguyen, G Gobbi
European Neuropsychopharmacology 19 (3), 215-228, 2009
The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium
S Comai, M Tau, Z Pavlovic, G Gobbi
Journal of clinical psychopharmacology 32 (2), 237-260, 2012
Hallucinogens in mental health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine
D De Gregorio, A Aguilar-Valles, KH Preller, BD Heifets, M Hibicke, ...
Journal of Neuroscience 41 (5), 891-900, 2021
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand
R Ochoa-Sanchez, S Comai, B Lacoste, FR Bambico, ...
Journal of Neuroscience 31 (50), 18439-18452, 2011
The system can't perform the operation now. Try again later.
Articles 1–20